278 related articles for article (PubMed ID: 29500585)
1. Comparing the effects of oxazepam and diazepam in actual highway driving and neurocognitive test performance: a validation study.
Jongen S; Vuurman EFPM; Ramaekers JG; Vermeeren A
Psychopharmacology (Berl); 2018 Apr; 235(4):1283-1294. PubMed ID: 29500585
[TBL] [Abstract][Full Text] [Related]
2. On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.
Vermeeren A; Vets E; Vuurman EF; Van Oers AC; Jongen S; Laethem T; Heirman I; Bautmans A; Palcza J; Li X; Troyer MD; Wrishko R; McCrea J; Sun H
Psychopharmacology (Berl); 2016 Sep; 233(18):3341-51. PubMed ID: 27424295
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivation.
Jongen S; Perrier J; Vuurman EF; Ramaekers JG; Vermeeren A
PLoS One; 2015; 10(2):e0117045. PubMed ID: 25668292
[TBL] [Abstract][Full Text] [Related]
4. On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers.
Vermeeren A; Sun H; Vuurman EF; Jongen S; Van Leeuwen CJ; Van Oers AC; Palcza J; Li X; Laethem T; Heirman I; Bautmans A; Troyer MD; Wrishko R; McCrea J
Sleep; 2015 Nov; 38(11):1803-13. PubMed ID: 26039969
[TBL] [Abstract][Full Text] [Related]
5. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
6. On-the-road driving performance the morning after bedtime administration of lemborexant in healthy adult and elderly volunteers.
Vermeeren A; Jongen S; Murphy P; Moline M; Filippov G; Pinner K; Perdomo C; Landry I; Majid O; Van Oers ACM; Van Leeuwen CJ; Ramaekers JG; Vuurman EFPM
Sleep; 2019 Apr; 42(4):. PubMed ID: 30597112
[TBL] [Abstract][Full Text] [Related]
7. The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.
van de Loo AJAE; Bervoets AC; Mooren L; Bouwmeester NH; Garssen J; Zuiker R; van Amerongen G; van Gerven J; Singh J; der Ark PV; Fedgchin M; Morrison R; Wajs E; Verster JC
Psychopharmacology (Berl); 2017 Nov; 234(21):3175-3183. PubMed ID: 28755104
[TBL] [Abstract][Full Text] [Related]
8. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects.
Mets MA; de Vries JM; de Senerpont Domis LM; Volkerts ER; Olivier B; Verster JC
Sleep; 2011 Oct; 34(10):1327-34. PubMed ID: 21966064
[TBL] [Abstract][Full Text] [Related]
9. Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.
Leufkens TR; Lund JS; Vermeeren A
J Sleep Res; 2009 Dec; 18(4):387-96. PubMed ID: 19552733
[TBL] [Abstract][Full Text] [Related]
10. The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.
Miyata A; Iwamoto K; Kawano N; Kohmura K; Yamamoto M; Aleksic B; Ebe K; Noda A; Noda Y; Iritani S; Ozaki N
Psychopharmacology (Berl); 2015 Jun; 232(12):2127-37. PubMed ID: 25533998
[TBL] [Abstract][Full Text] [Related]
11. A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
Strand MC; Vindenes V; Gjerde H; Mørland JG; Ramaekers JG
Br J Clin Pharmacol; 2019 Feb; 85(2):442-453. PubMed ID: 30515857
[TBL] [Abstract][Full Text] [Related]
12. Effects of alprazolam on driving ability, memory functioning and psychomotor performance: a randomized, placebo-controlled study.
Verster JC; Volkerts ER; Verbaten MN
Neuropsychopharmacology; 2002 Aug; 27(2):260-9. PubMed ID: 12093599
[TBL] [Abstract][Full Text] [Related]
13. Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype.
Ramaekers JG; Conen S; de Kam PJ; Braat S; Peeters P; Theunissen EL; Ivgy-May N
Psychopharmacology (Berl); 2011 May; 215(2):321-32. PubMed ID: 21246188
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
Ramaekers JG
J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
[TBL] [Abstract][Full Text] [Related]
15. Does a medicinal dose of kava impair driving? A randomized, placebo-controlled, double-blind study.
Sarris J; Laporte E; Scholey A; King R; Pipingas A; Schweitzer I; Stough C
Traffic Inj Prev; 2013; 14(1):13-7. PubMed ID: 23259514
[TBL] [Abstract][Full Text] [Related]
16. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
17. Driving performance and neurocognitive skills of long-term users of sedating antidepressants.
van der Sluiszen NNJJM; Vermeeren A; van Dijken JH; J A E van de Loo A; Veldstra JL; de Waard D; C Verster J; A Brookhuis K; Ramaekers JG
Hum Psychopharmacol; 2021 Jan; 36(1):1-12. PubMed ID: 33001492
[TBL] [Abstract][Full Text] [Related]
18. Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment.
Vinckenbosch FRJ; Vermeeren A; Verster JC; Ramaekers JG; Vuurman EF
Psychopharmacology (Berl); 2020 Mar; 237(3):877-886. PubMed ID: 31897572
[TBL] [Abstract][Full Text] [Related]
19. MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.
Kuypers KP; Samyn N; Ramaekers JG
Psychopharmacology (Berl); 2006 Sep; 187(4):467-75. PubMed ID: 16830130
[TBL] [Abstract][Full Text] [Related]
20. A dose-ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo.
Theunissen EL; Vermeeren A; van Oers AC; van Maris I; Ramaekers JG
Clin Exp Allergy; 2004 Feb; 34(2):250-8. PubMed ID: 14987305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
